Separate and interacting effects within the catechol-O-methyltransferase (COMT) are associated with schizophrenia

Molecular Psychiatry

Volumn 10, Issue 6, 2005, Pages 589-597

  Handoko, H Y ^a,b   Nyholt, D R ^b   Hayward, N K ^b   Nertney, D A ^a   Hannah, D E ^a   Windus, L C ^a   McCormack, C M ^a   Smith, H J ^a,b   Filippich, C ^a,b   James, M R ^b   Mowry, B J ^a,c  

^a QUEENSLAND CENTRE FOR MENTAL HEALTH RESEARCH   (Australia)

^b ROYAL BRISBANE AND WOMEN'S HOSPITAL   (Australia)

^c UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

Chromosome 22; Complex disorder; COMT; Dopamine; Schizophrenia; Single nucleotide polymorphism

Indexed keywords

CATECHOL METHYLTRANSFERASE; DOPAMINE; METHIONINE; VALINE;

ADULT; ARTICLE; AUSTRALIA; CAUCASIAN; CHROMOSOME 22Q; CONTROLLED STUDY; FAMILIAL DISEASE; GENDER; GENE LINKAGE DISEQUILIBRIUM; GENE MAPPING; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RISK FACTOR; SCHIZOPHRENIA; SINGLE NUCLEOTIDE POLYMORPHISM; VELOCARDIOFACIAL SYNDROME;

AMINO ACID SUBSTITUTION; AUSTRALIA; CATECHOL O-METHYLTRANSFERASE; CHROMOSOMES, HUMAN, PAIR 22; EUROPEAN CONTINENTAL ANCESTRY GROUP; FAMILY; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LINKAGE DISEQUILIBRIUM; MALE; PEDIGREE; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS; SCHIZOPHRENIA;

EID: 21244453517     PISSN: 13594184     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.mp.4001606     Document Type: Article

References (44)

1. Pulver AE, Nestadt G, Goldberg R, Shprintzen RJ, Lamacz M, Wolyniec PS et al. Psychotic illness in patients diagnosed with velo-cardio-facial syndrome and their relatives. J Nerv Ment Dis 1994; 182: 476-478.
2. Murphy KC, Jones LA, Owen MJ. High rates of schizophrenia in adults with velo-cardio-facial syndrome. Arch Gen Psychiatry 1999; 56: 940-945.
3. Ivanov D, Kirov G, Norton N, Williams HJ, Williams NM, Nikdlov I et al. Chromosome 22q11 deletions, velo-cardio-facial syndrome and early-onset psychosis. Molecular genetic study. Br J Psychiatry 2003; 183: 409-413.
4. Lindsay EA, Goldberg R, Jurecic V, Morrow B, Carlson C, Kucherlapati RS et al. Velo-cardio-facial syndrome: frequency and extent of 22q11 deletions. Am J Med Genet 1995; 57: 514-522.
5. Lewis CM, Levinson DF, Wise LH, DeLisi LE, Straub RE, Hovatta I et al. Genome scan meta-analysis of schizophrenia and bipolar disorder, part II: Schizophrenia. Am J Hum Genet 2003; 73: 34-48.
6. Badner JA, Gershon ES. Meta-analysis of whole-genome linkage scans of bipolar disorder and schizophrenia. Mol psychiatry 2002; 7: 405-411.
7. Lotta T, Vidgren J, Tilgmann C, Ulmanen I, Melen K, Julkunen I et al. Kinetics of human soluble and membrane-bound catechol O-methyltransferase: a revised mechanism and description of the thermolabile variant of the enzyme. Biochemistry 1995; 34: 4202-4210.
8. Shield AJ, Thomae BA, Eckloff BW, Wieben ED, Weinshilboum RM. Human catechol O-methyltransferase genetic variation: gene resequencing and functional characterization of variant allozymes. Mol Psychiatry 2004; 9: 151-160.
9. Lachman HM, Papolos DF, Saito T, Yu YM, Szumlanski CL, Weinshilboum RM. Human catechol-O-methyltiansferase pharmacogenetics: description of a functional polymorphism and its potential application to neuropsychiatric disorders. Pharmacogenetics 1996; 6: 243-250.
10. Egan MF, Goldberg TE, Kolachana BS, Callicott JH, Mazzanti CM, Straub RE et al. Effect of COMT Val108/158 Met genotype on frontal lobe function and risk for schizophrenia. Proc Natl Acad Sci USA 2001; 98: 6917-6922.
11. Joober R, Gauthier J, Lal S, Bloom D, Lalonde P, Rouleau G et al. Catechol-O-methyltransferase Val-108/158-Met gene variants associated with performance on the Wisconsin Card Sorting Test. Arch Gen Psychiatry 2002; 59: 662-663.
12. Malhotra AK, Kestler LJ, Mazzanti C, Bates JA, Goldberg T, Goldman D. A functional polymorphism in the COMT gene and performance on a test of prefrontal cognition. Am J Psychiatry 2002; 159: 652-654.
13. Li T, Sham PC, Vallada H, Xie T, Tang X, Murray RM et al. Preferential transmission of the high activity allele of COMT in schizophrenia. Psychiatr Genet 1996; 6: 131-133.
14. Li T, Ball D, Zhao J, Murray RM, Liu X, Sham PC et al. Family-based linkage disequilibrium mapping using SNP marker haplotypes: application to a potential locus for schizophrenia at chromosome 22q11. Mol Psychiatry 2000; 5: 77-84.
15. Glatt SJ, Faraone SV, Tsuang MT Association between a functional catechol O-methyltransferase gene polymorphism and schizophrenia: meta-analysis of case-control and family-based studies. Am J Psychiatry 2003; 160: 469-476.
16. Shifman S, Bronstein M, Sternfeld M, Pisante-Shalom A, Lev-Lehman E, Weizman A et al. A highly significant association between a COMT haplotype and schizophrenia. Am J Hum Genet 2002; 71: 1296-1302.
17. APA. Diagnostic and Statistical Manual of Mental Disorders. American Psychiatric Association: Washington, DC, 1994.
18. Owen MJ, O'Donovan MC, Gottesman II. Schizophrenia. In: McGuffin P, Owen MJ, Gottesman II (eds) Psychiatric Genetics and Genomics. Oxford University Press: Oxford. 2002 pp 247-266.
19. Levinson DF, Mowry BJ. Genetics of Schizophrenia. In: Pfaff DW, Berrettini WH, Maxson SC, Joh TH (eds) Genetic Influences on Neural and Behavioural Functions. CRC Press: New York, 2000 pp 47-82.
20. Nurnberger Jr JI, Blehar MC, Kaufmann CA, York-Cooler C, Simpson SG, Harkavy-Friedman J et al. Diagnostic interview for genetic studies: rationale, unique features, and training. Arch Gen Psychiatry 1994; 51: 849-859.
21. NIMH. Family Interview for Genetic Studies (FIGS). National Institute of Mental Health: Washington, DC, 1999.
22. Sun X, Ding H, Hung K, Guo B. A new MALDI-TOF based mini-sequencing assay for genotyping of SNPS. Nucleic Acids Res 2000; 28: E68.
23. Bray MS, Boerwinkle E, Doris PA. High-throughput multiplex SNP genotyping with MALDI-TOF mass spectrometry: practice, problems and promise. Hum Mutat 2001; 17: 296-304.
24. Cubells JF, Kobayashi K, Nagatsu T, Kidd KK, Kidd JR, Calafell F et al. Population genetics of a functional variant of the iopamine beta-hydroxylase gene (DBH). Am J Med Genet 1997; 74: 374-379.
25. Nyholt DR. A simple correction for multiple testing for single-nucleotide polymorphisms in linkage disequilibrium with each other. Am J Hum Genet 2004; 74: 765-769.
26. Dudbridge F. Pedigree disequilibrium tests for multilocus haplotypes. Genet Epidemiol 2003; 25: 115-121.
27. Terwilliger JD, Ott J. A haplotype-based 'haplotype relative risk' approach to detecting allelic associations. Hum Hered 1992; 42: 337-346.
28. Fallin D, Schork NJ. Accuracy of haplotype frequency estimation for biallelic loci, via the expectation-maximization algorithm for unphased diploid genotype data. Am J Hum Genet 2000; 67: 947-959.
29. Mander AP. Haplotype analysis in population-based association studies. Stata J 2001; 1: 58-75.
30. Agresti A, Coull BA. Approximate is better than 'exact' for interval estimation of binomial proportions. Am Statist 1998; 52: 119-126.
31. Brown LD, Cai TT, DasGupta A. Interval estimation for a binomial proportion. Statist Sci 2001; 16: 101-133.
32. Wilson EB. Probable inference, the law of succession, and statistical inference. J Am Statist Assoc 1927; 22: 209-212.
33. Clayton D. A generalization of the transmission/disequilibrium test for uncertain-haplotype transmission. Am J Hum Genet 1999; 65: 1170-1177.
34. Kilding R, Iles MM, Timms JM, Worthington J, Wilson AG. Additional genetic susceptibility for rheumatoid arthritis telomeric of the DRB1 locus. Arthritis Rheum 2004; 50: 763-769.
35. Chen X, Wang X, O'Neill AF, Walsh D, Kendler KS. Variants in the catechol-o-methyltransferase (COMT) gene are associated with schizophrenia in Irish high-density families. Mol Psychiatry, advance online publication May 4, 2004.
36. Tenhunen J, Salminen M, Lundstrom K, Kiviluoto T, Savolainen R, Ulmanen I. Genomic organization of the human catechol O-methyltransferase gene and its expression from two distinct promoters. Eur J Biochem 1994; 223: 1049-1059.
37. Bray NJ, Buckland PR, Williams NM, Williams HJ, Norton N, Owen MJ et al. A haplotype implicated in schizophrenia susceptibility is associated with reduced COMT expression in human brain. Am J Hum Genet 2003; 73: 152-161.
38. Palmatier MA, Pakstis AJ, Speed W, Paschou P, Goldman D, Odunsi A et al. COMT haplotypes suggest P2 promoter region relevance for schizophrenia. Mol Psychiatry 2004; 9: 859-870.
39. Xu Q, Jia YB, Zhang BY, Zou K, Tao YB, Wang YP et al. Association study of an SNP combination pattern in the dopaminergic pathway in paranoid schizophrenia: a novel strategy for complex disorders. Mol Psychiatry 2004; 9: 510-521.
40. Kunugi H, Vallada HP, Sham PC, Hoda F, Arranz MJ, Li T et al. Catechol-O-methyltransferase polymorphisms and schizophrenia: a transmission disequilibrium study in multiply affected families. Psychiatr Genet 1997; 7: 97-101.
41. Purcell S, Cherny SS, Sham PC. Genetic Power Calculator: design of linkage and association genetic mapping studies of complex traits. Bioinformatics 2003; 19: 149-150.
42. Suarez BK, Hodge SE. A simple method to detect linkage for rare recessive diseases: an application to juvenile diabetes. Clin Genet 1979; 15: 126-136.
43. Knapp M. A note on power approximations for the transmission/ disequilibrium test. Am J Hum Genet 1999; 64: 1177-1185.
44. Antoniou AC, Easton DF. Polygenic inheritance of breast cancer: implications for design of association studies. Genet Epidemiol 2003; 25: 190-202.